1. Introduction {#sec1}
===============

Since prehistory, plants and their by-products were used to treat wounds. Cramoll 1.4 is lectin extracted from seeds of *Cratylia mollis*Mart, a plant native to northeastern Brazil. Cramoll is specific for glucose/mannose. Four multiple forms have been purified from *C*.*mollis*---Cramoll 1, Cramoll 2, Cramoll 3, Cramoll 4---and preparations containing multiple combined forms as 1 and 4, named Cramoll 1.4 \[[@B1]\]. Studies have demonstrated that Cramoll 1,4 is capable of (i) isolating glycoproteins from human plasma \[[@B2]\], (ii) characterizing transformed mammary tissue \[[@B3]\], (iii) inducing mitogenic activity in human lymphocytes \[[@B4]\], (iv) producing IFN-y and nitric oxide \[[@B5]\], and (v) antitumor activities \[[@B6]\].

Burn wounds are one of the health problems in modern societies associated with irreparable harms and side many problems for patients and their families \[[@B7]\]. Burns are classified by their depth and severity such as 1st, 2nd, 3rd, and 4th degrees. The pathophysiologic reaction to a burn injury is complex and varies with the cause (thermal, chemical, electrical, or radiation). In thermal injuries, changes in the burn wound are mainly caused by heat direct effects, but superimposed on these are changes associated with the acute inflammatory process. It is these latter changes that account for the widespread and devastating effects of major burns on the entire body\'s homeostatic function \[[@B8]\]. In addition to the physiological morbidity of burns, these types of injuries are associated with a huge financial burden on the public health system.

In order to ease the pain of burning and minimize the number of dressing changes, several studies have been carried out in search of formulations that help in healing. The advent of dry bandages occurred in the nineteenth century due to the germ theory authored by Louis Pasteur. In the twentieth century, with advances in knowledge about the mechanisms involved in tissue lesion healing, the theory that the wounds in a wet environment have better healing capacity was developed \[[@B9]\]. In order to meet this need, the wet bandages containing natural and synthetic molecules have shown significant effect on the healing mechanism. In this sense, aiming to evaluate the effects of topical application of hydrogel containing 1, 4 Cramoll isolectin, this study investigated *in vivo* the clinical and histopathological features of second-degree thermal burns demonstrated experimentally in rats of Wistar strain.

2. Materials and Methods {#sec2}
========================

2.1. Plant Material {#sec2.1}
-------------------

### 2.1.1. Cratylia Mollis (Extraction and Purification) {#sec2.1.1}

Cramoll 1,4 isolectin was purified from a 10% (w/v) seed extract of Cratylia mollis in 0.15 M NaCl according to the protocol reported in Correia and Coelho \[[@B10]\]. Briefly, all seeds (Camaratu bean) collected in Ibimirim City, State of Pernambuco, were washed with distilled water, dried at room temperature, and blended in 0.15 M NaCl. After 16 h of gently stirring at 4°C, the extract was filtered and centrifuged for 12 000 g. The extract was ammonium sulfate fractionated, dialysed against 0.15 M NaCl (fraction 40--60%) and affinity chromatographed on Sephadex G-75 (Sigma Chemical Company) in column (70.0 × 1.9 cm) containing 200 mL packed matrix, balanced with 0.15 M NaCl. After sample application, 0.15 M NaCl was passed through the column until *A*280 nm was less than 0.1; isolectin was eluted with 0.3 M glucose in 0.15 M NaCl. Fractions with highest *A*280 nm were pooled, exhaustively dialysed in buffer citrate phosphate and then lyophilized. The native isolectin has 8.5-8.6 pI measured by isoelectric focusing in polyacrylamide gel and 31 Kda main polypeptide.

2.2. Isolectin Hydrogel {#sec2.2}
-----------------------

Carbopol was used as vehicle suspended in boric acid buffer (pH 6.0) at 25°C. After extraction and purification, Cramoll 1,4 solutions were added in sufficient quantity to achieve the final concentration of 100 *μ*g Cramoll 1,4 per mL of hydrogel. Irradiation was performed at room temperature using Co^60^ at 15 kGy h^−2^ \[[@B11]\].

### 2.2.1. Evaluation of Hemagglutinating Activity of the Isolectin Hydrogel {#sec2.2.1}

The hemagglutinating activity was performed in microtiter plates according to Correia and Coelho \[[@B10]\]. Samples of isolectin hydrogel (50 *μ*L) were serially diluted in 0.15 M NaCl before adding 5 *μ*L of a 2.5% (v/v) rabbit erythrocytes suspension previously treated with glutaraldehyde. The title was expressed as the highest dilution showing hemagglutinating activity. Assay performed in triplicate.

2.3. Animals and Experimental Wounds {#sec2.3}
------------------------------------

### 2.3.1. Animals {#sec2.3.1}

All animals received humane care, and studies reported in this paper have been carried out in accordance with the guidelines for human treatment of animals set by the Brazilian College of Animal Experiment. The study was approved by the Committee on Animal Research at the Federal University of Pernambuco, Brazil (23076.015015/2009-31). A total of twenty male Wistar rats (*Rattus norvegicus*, albinus), 8--10-week-old and weighing approximately 250--300 g, were used in this study. Food pellets and water were provided ad *libitum* throughout the experiment.

### 2.3.2. Burn Injury {#sec2.3.2}

Animals were divided randomly into two groups of 10 (G1 and G2) and preanesthetized with atropine sulfate at 0.04 mg kg^−1^ intramuscularly. After ten minute, an anesthetic combination was used through an intramuscular injection of xylazine 10 mg kg^−1^ and ketamine 90 mg kg^−1^ with subsequent dorsum trichotomy by direct hair tension (area measuring approximately 3 cm^2^) ([Figure 1(a)](#fig1){ref-type="fig"}) and antisepsis with 1% polyvinylpyrrolidone-iodine. Burns were symmetrically caused on depilated areas through contact with an aluminum bar (*r* = 10 mm), preheated for 100°C for 15 s ([Figure 1(b)](#fig1){ref-type="fig"}). After burn injury and animal awakening, once the procedure completed, analgesia was processed by means of intramuscular dipyrane application (0.01 mg kg^−1^) to prevent pain. Injuries were observed during 35 consecutive days followed by the application of 100 *μ*L hydrogel on the burn ([Figure 1(c)](#fig1){ref-type="fig"}). Group-1 was treated with empty hydrogel containing 100 *μ*g Cramoll 1,4. Group-2 (control) was treated with hydrogel without isolectin.

2.4. Pathological Observations {#sec2.4}
------------------------------

### 2.4.1. Clinical Parameters {#sec2.4.1}

Burns surface was evaluated based on the following parameters for 35 consecutive days: edema, hyperemia, exudation and the firmness of wound surface, and presence or absence of granulation tissue and scar tissue. Wounds were considered closed if moist granulation tissue was no longer apparent and wounds seemed covered with new epithelium. Body weight was determined using electronic balance (accuracy to g) on the day of burn induction as well as days 7, 14, 21, 28, and 35 after wounding.

### 2.4.2. Wound Retraction Quantification {#sec2.4.2}

All the rats were examined weekly under anesthesia for observation of wound contracture. The wound retraction was evaluated in 7, 14, 21, 28, and 35 days after burn induction. Wound contraction was expressed as reduction in percentage of original wound size. % wound contraction on day-X = \[(area on day 0 − open area on day X)/area on day 0\] × 100 \[[@B12]\].

### 2.4.3. Biochemical and Hematological Evaluations {#sec2.4.3}

Blood from two animals per group were collected on days 7, 14, 21, 28, and 35 after burn induction for biochemical determination. Levels of creatinine, urea, glutamic pyruvic transaminase, glutamic oxalacetic transaminase, gamma glutamyl transferase, amylase, alkaline phosphatase, calcium, prothrombin, and fibrinogen were determined. Hematological parameters (erythrocytes, leukocytes, and platelets) were determined immediately after blood collection. Evaluations performed in triplicate. Animals in both G1 and G2 were sacrificed by injecting 30 mg kg^−1^ thiopental sodium.

### 2.4.4. Histopathology {#sec2.4.4}

After collection, tissue samples were fixed in 4% formaldehyde (v/v) prepared in PBS (0.01 M, pH 7.2) followed by histological processing through paraffin embedding, microtome with 4 *μ*m cuts, and Masson\'s trichrome and hematoxylin-eosin staining. Histological analysis was performed by comparative descriptive analysis of experimental groups in binocular optical microscope (Zeiss-Axiostar model), where cellular and tissue characteristics of skin were evaluated after thermal injury and subsequent healing pattern.

2.5. Statistical Analysis {#sec2.5}
-------------------------

Data were analyzed using nonparametric tests. To detect differences between groups, the Mann-Whitney *U* test was used. All results were expressed as mean values of groups ± standard deviation and analyzed considering *P* \< 0.05 as statistically significant.

3. Results and Discussion {#sec3}
=========================

Overall, all animals were clinically well (showing normal behavior of species and ingestion of food and water) during the experiments. There was no bleeding during surgery. Neither the rats under treatment nor the control group showed any statistically significant changes on the body weight throughout the experiments, showing that analgesia was adequate for the injury caused. As reported by Hellebrekers \[[@B13]\], the main signs of pain in laboratory animals subjected to experimental procedures are directly related to changes in behavior, with anorexia being one of the most significant signs.

3.1. Hemagglutinating Activity {#sec3.1}
------------------------------

Due to the immunostimulating and mitogenic activities attributed to lectins, the therapeutic use of these proteins in tissue repair processes has been subject of much research either related to the lectin concentration or the formulation used \[[@B14]\].

Lectins or hemagglutinins can be detected and characterized by their ability to agglutinate erythrocytes. In the evaluation of hydrogel containing 1,4 isolectin Cramoll was observed that Cramoll-1,4 at 50 *μ*g/mL in both pure and gel formulation after irradiation lost their hemagglutinating activity. On the other hand, the concentration 100 *μ*g/mL remained constant for the irradiated pure isolectin and that combined to the hydrogel excipient ([Figure 2](#fig2){ref-type="fig"}).

Several aspects make the hydrogel an ideal bandage for treatment of tissue lesions, such as hydrophilicity, biocompatibility, nontoxicity, biodegradability, easy replacement, transparency, adhesion, absorption, and prevention of body fluid losses \[[@B15], [@B16]\]. Burd \[[@B17]\] evaluated the use of hydrogel sheet dressings in comprehensive burn wound care, noting that use of hydrogel in burn wound care reduces patient\'s pain sensation. Osti \[[@B18]\] evaluated the use of a transparent adhesive film possessing selective permeability combined with a hydrogel (Burnshield) in burns treatment. For about 2 years, this type of therapy was used in the first aid treatment of 48 burn patients, 4 were lost during therapy and 4 were unavailable for followingup. In the reepithelialization phase complications were recorded in 8 of the 40 patients: 7 (18%) had residual inflammation and 1 (2%) had hypertrophic scar. During the followup, late complications were recorded in 2 (5%) of the 40 patients. A gel was used in 8 patients: in 6 of the 7 patients with residual inflammation, the complication was solved, while in 1, despite therapy, the residual inflammation evolved into hypertrophic scarring.

3.2. Clinical Parameters {#sec3.2}
------------------------

Wound cooling caused by burn is an urgency measure, which proved to be beneficial in clinical and experimental practices. Hydrogels are cross-linking three-dimensional structures with high water percentage that can be transferred from the gel to the scar wound to facilitate hydration. The healing process of animals with aseptic experimental thermal burns treated topically with isolectin had better response than the control in the clinical examination in several ways such as (1) presence of edema in the first 24 h after induction of second-degree thermal burn, (2) thickening of the crust, which began to emerge spontaneously in 6 days of experiment, (3) discrete hyperemia observed in the range between 24 and 48 h after injury and (4) presence of scar tissue with 13 days of experiment ([Figure 3](#fig3){ref-type="fig"}). During the study period, lesions showed no signs of infection. Severely burned skin ceases to perform its natural protective and barrier role and allows a dramatic increase in water loss and can become a portal for bacterial invasion. The local treatment of second-degree burns is targeted at maintaining a wet microenvironment and stimulating the formation of a well-vascularised granulation tissue, and the reepithelization of the lesion while counteracting the development of microorganisms, which is able to delay or prevent the biological phenomena of cicatrization and reepithelization \[[@B19]\].

3.3. Wound Retraction Quantification {#sec3.3}
------------------------------------

The wound contraction is a parameter used for assessing wound healing. The lesion area decreased gradually with the progress of healing time in both groups. The significant wound contraction was initiated from day 14 in the G1 that showed highest rate of lesion contraction compared with G2, indicating that isolectin has an inducing effect on the lesion contraction as illustrated in [Figure 4](#fig4){ref-type="fig"}. These results are consistent with studies *in vitro* and *in vivo* performed by Sezer et al. \[[@B20]\], which demonstrated the efficacy of hydrogels in the treatment of dermal burns in rabbit model revealing that the application of fucoidan-chitosan hydrogel promotes burn wound contraction and induces healing.

Wound contraction, wound shrinking process, depends on the tissue\'s reparative abilities, type, and damage extent and tissue health general state \[[@B21]\]. On the other hand, the wound contraction is rarely able to take to its permanent closure, which is mainly due to the presence of fibroblasts found in the granulation tissue that later differentiates into myofibroblasts \[[@B22]\].

3.4. Biochemical and Hematological Evaluation {#sec3.4}
---------------------------------------------

Hematological values obtained in this study showed no significant changes as a function of burn induction during the period analyzed (erythrocytes: 7.6 ± 0.48, hemoglobin, 13.65 ± 0.5; platelets: 846400 ± 0.71, leukocytes: 7980 ± 0.71, basophils: 0.2 ± 0.05, eosinophils: 1.38 ± 0.18, lymphocytes: 82.37 ± 0.83, and Monocytes: 1.9 ± 0.2) ([Table 1](#tab1){ref-type="table"}), revealing normal values in rats \[[@B23]\]. Rats, like other mammals, have to maintain strict control of the internal environment thus ensuring homeostasis. It is known that rats can produce changes in these parameters as a result of pathological processes or external factors such as sex, ancestry, age, diet, handling, and environment \[[@B24]\].

However, average values of biochemical parameters analyzed in this study were consistent with previously reported specific data to normal animals (calcium: 10.04 ± 0.42, pro-Thrombin: 9.94 ± 0.16, fibrinogen: 457.32 ± 0.25, alkaline phosphatase: 212.68 ± 0.52, glutamic oxalic transaminase: 180.02 ± 0.35, glutamic pyruvic transaminase: 53.28 ± 0.41, gamma-glutamyl transpeptidase: 5.76 ± 0.23, creatine: 0.54 ± 0.04, urea: 46.34 ± 0.04 and amylase: 842.06 ± 0.48) ([Table 2](#tab2){ref-type="table"}). The biochemical evaluation revealed increased ALT levels in response to injury by burning and alkaline phosphatase-related to inflammatory period of the healing process. On the other hand, metabolic changes are considered high risk in third-degree burns with hyperglycemia \[[@B25]\] and high protein catabolism \[[@B26]\] as the main aggravating factors to the injury.

After burn trauma, inflammatory mediators, oxygen-free radicals, and arachidonic acid metabolites and complement \[[@B27]\], released in the wounds, promote a great edema. According to Beukelman et al. \[[@B28]\], liposomal hydrogel with 3% povidone-iodine (PVP-ILH, Repithel) has shown clinical benefit in settings where inflammation and/or reactive oxygen species are thought to impede wound healing (e.g., burns and chronic wounds in smokers). According to Møller-Kristensen et al. \[[@B29]\], the MBL, mannan-binding lectin, modulates not only inflammatory factors such as cytokines and chemokines, but also cell adhesion molecules, the binding growth factor protein, and, MPPs in particular, metalloproteinase matrix, which are most likely the direct effectors in scabs detachment.

Considering the influence of carbohydrates in numerous cell signaling phenomena whether physiological or pathological, the use of lectins in the treatment of cutaneous lesions among other diseases stimulates the activation and modulation events such as communication, cellular differentiation, and proliferation \[[@B30]--[@B32]\].

3.5. Histopathology {#sec3.5}
-------------------

Deep partial thickness burns are injuries that cause partial or total destruction of nerve endings, hair follicles, and sweat glands. On the seventh day was observed intense fibroblastic proliferation, neovascularization, necrosis, and edema. In upper layer of dermis, most hair follicle walls, sebaceous follicles, and sudoriparous glands disappeared and only their residual bodies could be found. Capillary vessels were fractured. The epidermis showed necrosis with infiltration of large numbers of neutrophils and few monocytes, leukocytes, and plasma of the dermis ([Figure 5(b)](#fig5){ref-type="fig"}). These data are similar to observations reported by Nunes et al. \[[@B33]\] that when evaluating the application of a collagen film containing acid usnic as bandage to treat second-degree thermal burns, an intense inflammatory response after 7 days with presence of neutrophils distributed throughout the length of the burn was found.

With 14 days of experiment, G1 and G2 showed granulation tissue with presence of discrete neovascularization and neoformation of skin appendages. Angiogenesis is essential to restore the supply of nutrients and oxygen during tissue healing \[[@B34]\]. In group 1, an increased number of fibroblasts was observed, and presence of collagen was organized in the lesion center ([Figure 5(c)](#fig5){ref-type="fig"}). Experiments performed by Sezer et al. \[[@B35]\] demonstrated that fibroblast and collagen amounts in fucosphere-treated groups increased at day 14 compared to that at day seven, but decreased at day 21. The reepithelialization time was lower for animals treated with isolectin hydrogel and started around the burn edge on the 14th day. Epithelialization is necessary in the repair of all type of wounds if water tight seal occurs. Protection from fluid and particulate-matter contamination and maintenance of internal milieu are dependent on keratin\'s physical characteristic \[[@B36]\]. The experimentally induced thermal injuries have been completely reepithelialized in both groups with 35 days.

Histopathology revealed the intense fibroblast proliferation at 21st day, presence of dense collagen, and not modeled and moderate fibrosis ([Figure 5(d)](#fig5){ref-type="fig"}). Collagen deposition in the fibroplasia phase is required for the efficient arrival of fibroblasts to the burn site. Mature fibroblasts produce a delicate matrix that gives mechanical support to the new capillaries \[[@B37]\]. The collagen deposited at the injury site will not have the same unique organization of an intact tissue, being required a period of two months to complete restructure \[[@B38]\]. The decrease in epithelium thickness on the day 21 was considered by Sezer et al. \[[@B39]\] as the result of higher healing rate, particularly on the superficial burn wound treated with chitosan film containing fucoidan.

After 28 days, both G1 and G2 showed gradual decrease in the number of fibroblasts with greater organization of the collagen matrix with reduced inflammatory infiltration ([Figure 5(e)](#fig5){ref-type="fig"}). Finally, 35 days after burn procedures, the injured tissue of group 1 is at the stage of maturation and remodeling, with the presence of few fibroblasts and inflammatory cells ([Figure 5(f)](#fig5){ref-type="fig"}). The histological analysis of liver sections in group G1 showed no cytotoxic effects resulting from topical application of isolectin hydrogel at the end of treatment after 35 days. These results are consistent with previous studies performed by our group that found the healing action of isoforms 1 and 4 of *Cratylia mollis*lectin in the repair of skin wounds in normal and immunosuppressed mice \[[@B40]\].

Several studies have confirmed the use of lectins in the immune system activation, enlisting neutrophils through indirect mechanisms \[[@B41]\], promoting proinflammatory effects in polymorphonuclear cells and inducing the cytokines release \[[@B42]\], as well as triggering fibroblasts proliferation \[[@B43]\]. Previous assays accomplished by our group have shown a potential proinflammatory and immunomodulatory activity induced by Cramoll 1,4 lectin. The importance of glycoproteins (including lectins) as components of *Aloe vera* extract gel has been asserted for promoting wound, burn, and frost-bite healing, and showing anti-inflammatory and antifungal properties \[[@B44]\]. Sell and Costa \[[@B45]\] also described improved effect of PHA lectin in the skin tissue repair process of Wistar rats compared to *Triticum vulgaris* (WGA) and *Artocarpus integrifolia* (jacalin) lectin.

4. Conclusion {#sec4}
=============

The present study has demonstrated that the regular topical application of Cramoll 1,4 hydrogel containing in the treatment of second-degree burns accelerates the granulation, reepithelialization process, and wound retraction. These results extend the potential of therapeutic applications of isolectin Cramoll 1,4, which can be used in combination with other byproducts in the treatment of thermal burns.
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![Induction of second-degree thermal burns in male Wistar rats. (a) Back trichotomy by direct hair tension, (b) depth second-degree thermal burn with *r* = 10 mm, (c) treatment of thermal burn using 100 *μ*L hydrogel.](JBB2012-184538.001){#fig1}

![Evaluation of hemagglutinating activity of 1,4 Cramoll isolectin combined to the hydrogel excipient. Cra 50: Pure Cramoll 1,4 isolectin at 50 *μ*g/mL. Cra 50 I: Pure Cramoll 1,4 isolectin at 50 *μ*g/mL irradiated (15 k Gy h^−2^). Cra IG: Pure Cramoll 1,4 isolectin at 50 *μ*g/mL associated with hydrogel excipient and irradiated (15 k Gy h^−2^). Cra 100: Pure Cramoll 1,4 isolectin at 100 *μ*g/mL. Cra 100 I: Pure Cramoll 1,4 isolectin at 100 *μ*g/mL irradiated (15 k Gy h^−2^). Cra IG 100: Pure Cramoll 1,4 isolectin at 100 *μ*g/mL associated with hydrogel excipient and irradiated (15 k Gy h^−2^). Hydrogel irradiated without lectin. The title was expressed as the highest dilution showing hemagglutinating activity. Values are mean ± SEM.](JBB2012-184538.002){#fig2}

![Clinical evaluation of second-degree burn healing in Wistar male rats. G1: experimental group treated with hydrogel containing isolectin Cramoll 1,4 at 100 *μ*g/mL. (a) Thermal lesion aspect after 7 days: macroscopically shows thin and dry crust with detachment of edges. (b) Thermal lesion aspect after 14 days of treatment: absence of crust and the presence of scar tissue. (c) Thermal lesion aspect after 21 days of treatment: presence of scar tissue and a small detachment point of the crust. (d) Thermal lesion aspect after 28 days of treatment: presence of scar tissue only. (e) Thermal lesion aspect after 35 days of treatment: view of a discrete scar tissue. G2: control group treated by topical application of hydrogel excipient. (f) Thermal lesion aspect in control animals after 7 days: view of thin and dry crust with detachment of edges. (g) Thermal lesion aspect in control animals after 14 days: absence of crust and the presence of scar tissue. (h) Thermal lesion aspect in control animals after 21 days: presence of scar tissue, with the point of detachment of the crust. (i) Thermal lesion aspect in control animals after 28 days: presence of scar tissue and a second crust. (j) Thermal lesion aspect in control animals after 35 days: view of scar tissue.](JBB2012-184538.003){#fig3}

![Effect of hydrogel topical application on the burn wound expressed as percentage of wound contraction. G1 = Treatment, G2 = Control. *n* = 2. Values are mean ± SEM. \**P* \< 0.05.](JBB2012-184538.004){#fig4}

![Epithelial tissue of rats in group 1 subjected to second-degree thermal burns. Masson\'s trichrome staining. 100x Magnification. (a) Normal epithelial tissue with all skin appendages. (b) Animal presenting epithelial tissue with complete destruction of the dermis and epidermis showing exudates albumin/leukocyte/macrophage intense, necrosis, edema, and crust at the 7th day after injury induction. (c) Animal at the 14th day with tissue reepithelialization, moderate autolysis, moderate exudate albumin/leukocyte/macrophage, intense neovascularization, and discrete fibroblast proliferation with the presence of loose collagen and mild fibrosis. (d) Animal at the 21st day with incomplete tissue reepithelialization, mild exudate albumin/leukocyte/macrophage, moderate neovascularization, intense fibroblastic proliferation, and presence of dense collagen, not modeled and moderate fibrosis. (e) Animal at the 28th day with complete tissue epithelialization, exudate albumin/leukocyte/macrophage discrete in the epidermis, moderate fibroblastic proliferation, presence of modeled dense collagen mesh and moderate fibrosis. (f) Animal at the 35th day with complete reepithelialization, mild fibroblastic proliferation, and presence of modeled dense collagen mesh and moderate fibrosis.](JBB2012-184538.005){#fig5}

###### 

Effect of topical administration of hydrogel containing 100 *μ*g per mL isolectin Cramoll 1,4 on the hematological parameters of Wistar rats. Assays performed in triplicate for each parameter. G1 = Treatment, G2 = control. Mean ± SD (*n* = 2).

  Parameters               7th day           14th day        21st day        28th day       35th day                                                                        
  ------------------------ ----------------- --------------- --------------- -------------- --------------- --------------- --------------- --------------- --------------- ---------------
  **Erythrogram**                                                                                                                                                           
  Erythrocytes mil/mm^3^   6.7 ± 0.01        7.2 ± 0.14      7.1 ± 0.16      7.57 ± 0.69    7.6 ± 0.69      7.5 ± 0.42      6.32 ± 0.56     8.1 ± 0.21      6.3 ± 0.71      7.7 ± 0.92
  Hemoglobin g/dL          13.9 ± 0.01       13 ± 0.14       14.8 ± 0.52     15.59 ± 0.41   15.6 ± 0.41     12.4 ± 0.64     13.7 ± 0.38     12.8 ± 0.49     14.1 ± 0.32     14.5 ± 0.42
  Hematocrit %             38.7 ± 0.22       41.1 ± 0.49     40.6 ± 0.56     43.22 ± 0.96   43.2 ± 0.96     41 ± 0.85       38.5 ± 0.55     39.8 ± 0.92     41.9 ± 0.84     40.8 ± 0.49
  **Platelet count**                                                                                                                                                        
  Platelets mil/mm^3^      844000 ± 0.71     805000 ± 0.71   656000 ± 0.71   926000 ± 071   788000 ± 0.71   820000 ± 0.71   844000 ± 0.71   789000 ± 0.71   749000 ± 0.71   892000 ± 0.71
  **WBC**                                                                                                                                                                   
  Leukocytes %             7200 ± 0.71       8000 ± 0.71     8100 ± 0.71     7900 ± 0.71    12000 ± 0.71    8100 ± 0.71     9300 ± 0.71     7900 ± 0.71     8000 ± 0.71     8000 ± 0.71
  Neutrophils %            15.1 ± 0.07       26.8 ± 0.78     26.4 ± 0.28     31.3 ± 0.56    8.7 ± 0.63      28.8 ± 0.42     14.7 ± 0.71     27.5 ± 0.71     16.1 ± 0.2      33.1 ± 0.99
  Eosinophils %            0 ± 0             0.1 ± 0.14      0.1 ± 0.07      1.6 ± 0.28     0.1 ± 0.07      2.4 ± 0.28      0.1 ± 0.14      1.3 ± 0.14      0.1 ± 0         1.5 ± 0.07
  Basophils %              0.2 ± 0           0.2 ± 0.14      0.2 ± 0.07      0.2 ± 0        0.2 ± 0         0.2 ± 0.14      0.2 ± 0         0.2 ± 00        0.2 ± 0         0.1 ± 0
  typical lymphocytes %    81.4 ± 0.64       81.5 ± 0.49     68.5 ± 0.70     86.85 ± 0.78   87.1 ± 0.84     82.7 ± 0.49     81.5 ± 0.56     79.9 ± 0.71     83.7 ± 0.46     80.9 ± 0.78
  atypical lymphocytes %   0 ± 0             0 ± 00          0 ± 00          0 ± 00         0 ± 0           0 ± 0           0 ± 0           0 ± 00          0 ± 0           0 ± 0
  Monocytes %              1.4 ± 0.07        2 ± 0.71        1.2 ± 0.07      2 ± 00         1.2 ± 0.07      1.5 ± 0.71      1.4 ± 0.07      1.5 ± 0.71      1.2 ± 0.07      2.5 ± 0.71

###### 

Effect of topical administration of hydrogel containing 100 *μ*g per mL isolectin Cramoll 1,4 on the biochemical parameters of Wistar rats. Doses performed in triplicate for each parameter. G1 = Treatment, G2 = Control. Mean ± SD (*n* = 2).

  Parameters                            7th day        14th day       21st day       28th day       35th day                                                                    
  ------------------------------------- -------------- -------------- -------------- -------------- -------------- -------------- -------------- --------------- -------------- --------------
  Prothrombin time %                    10.1 ± 0.07    9.7 ± 0.02     9.62 ± 0.11    10.1 ± 0.21    9.2 ± 0.21     10.1 ± 0.28    10.5 ± 0.71    10.1 ± 0.436    10.5 ± 0.70    9.7 ± 0.56
  Fibrinogen mg/dL                      460.5 ± 0.71   457.9 ± 0.07   407.1 ± 0.14   460.8 ± 0.21   412 ± 0.71     465.6 ± 0.47   380 ± 0.92     440.1 ± 0.142   407.7 ± 0.41   462.2 ± 0.34
  Calcium mg/dL                         10.3 ± 0.14    9.6 ± 0.46     8.4 ± 0.98     9.6 ± 0.42     11.6 ± 0.14    9.4 ± 0.16     11.5 ± 0.71    11.5 ± 0.658    9.7 ± 0.59     10.1 ± 0.42
  Alkaline phosphatase U/L              193.6 ± 0.56   199.6 ± 0.49   212.7 ± 0.42   201.4 ± 0.57   208 ± 0.71     198.2 ± 0.31   275 ± 0.71     244.6 ± 0.601   209.7 ± 0.38   219.6 ± 0.62
  Gamma glutamyl transferase U/L        5 ± 00         5.9 ± 0.14     5.7 ± 0.35     5.7 ± 0.29     5.8 ± 0.14     5.9 ± 0.02     5.3 ± 0.07     5.2 ± 0.012     5.6 ± 0.14     6.1 ± 0.72
  Oxalic transaminase glutamic U/L      142 ± 0.07     176.6 ± 0.54   136.5 ± 0.71   208.2 ± 0.33   193 ± 0.71     179.9 ± 0.04   141.5 ± 0.64   156.6 ± 0.506   177.9 ± 0.15   178.8 ± 0.31
  Transaminase glutamico piruvica U/L   60.7 ± 0.42    50.8 ± 0.19    55.7 ± 0.04    54.5 ± 0.58    47 ± 0.42      48.7 ± 0.33    48.5 ± 0.63    51.9 ± 0.129    58.5 ± 0.71    60.5 ± 0.78
  Urea mg/dL                            46.3 ± 0.49    46.9 ± 0.05    43.7 ± 0.35    50.6 ± 0.91    40 ± 0.71      45.9 ± 0.06    41.5 ± 0.71    46.8 ± 0.331    37.9 ± 0.11    41.5 ± 0.68
  Creatinine mg/dL                      0.2 ± 0.07     0.6 ± 0.04     0.5 ± 0.07     0.6 ± 0.12     0.4 ± 0.07     0.6 ± 0.01     0.6 ± 0.04     0.50 ± 0.011    0.5 ± 0.14     0.4 ± 0.04
  Amylase U/L                           838 ± 0.14     846.6 ± 0.56   789 ± 0.71     866.7 ± 0.42   808.3 ± 0.87   887.5 ± 0.71   856.6 ± 0.84   799.7 ± 0.469   814.5 ± 0.71   809.8 ± 0.27

[^1]: Academic Editor: Monica Fedele
